Free Trial

Xenetic Biosciences (XBIO) Stock Price, News & Analysis

-0.05 (-1.33%)
(As of 05/21/2024 ET)
Today's Range
50-Day Range
52-Week Range
932 shs
Average Volume
5,480 shs
Market Capitalization
$5.73 million
P/E Ratio
Dividend Yield
Price Target
XBIO stock logo

About Xenetic Biosciences Stock (NASDAQ:XBIO)

Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.

XBIO Stock Price History

XBIO Stock News Headlines

Xenetic Biosciences Inc (XBIO)
Xenetic Dips on Full-Year Results
Xenetic Biosciences reports FY results
Xenetic Biosciences Inc XBIO
Xenetic Biosciences: Q3 Earnings Insights
MediciNova: Q3 Earnings Snapshot
XBIO Xenetic Biosciences, Inc.
XBIO.PH - | Stock Price & Latest News | Reuters
See More Headlines
Receive XBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xenetic Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Pharmaceutical preparations
Current Symbol
Year Founded


Net Income
Net Margins
Pretax Margin


Sales & Book Value

Annual Sales
$2.54 million
Book Value
$6.36 per share


Free Float
Market Cap
$5.73 million
Not Optionable

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Jeffrey F. Eisenberg (Age 53)
    CEO & Director
  • Mr. James F. Parslow (Age 54)
    CFO, COO & Corp. Sec.
  • Dr. Curtis A. Lockshin (Age 59)
    Chief Scientific Officer

XBIO Stock Analysis - Frequently Asked Questions

How have XBIO shares performed in 2024?

Xenetic Biosciences' stock was trading at $3.45 on January 1st, 2024. Since then, XBIO shares have increased by 7.8% and is now trading at $3.72.
View the best growth stocks for 2024 here

When is Xenetic Biosciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, August 9th 2024.
View our XBIO earnings forecast

How were Xenetic Biosciences' earnings last quarter?

Xenetic Biosciences Inc (NASDAQ:XBIO) posted its quarterly earnings data on Thursday, March, 21st. The company reported ($0.77) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.87) by $0.10. The business had revenue of $0.67 million for the quarter, compared to the consensus estimate of $0.68 million. Xenetic Biosciences had a negative trailing twelve-month return on equity of 43.40% and a negative net margin of 182.99%.

When did Xenetic Biosciences' stock split?

Xenetic Biosciences's stock reverse split before market open on Monday, May 15th 2023. The 1-10 reverse split was announced on Monday, May 15th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 15th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Xenetic Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Xenetic Biosciences investors own include VBI Vaccines (VBIV), Sorrento Therapeutics (SRNE), OPKO Health (OPK), Biocept (BIOC), Trevena (TRVN), TherapeuticsMD (TXMD), T2 Biosystems (TTOO), Vaxart (VXRT), Aytu BioPharma (AYTU) and Co-Diagnostics (CODX).

How do I buy shares of Xenetic Biosciences?

Shares of XBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:XBIO) was last updated on 5/21/2024 by Staff

From Our Partners